Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,060.65 -9.90 (-0.20%) Dow
38,371.50 -132.19 (-0.34%) Nasdaq
15,716.75 +20.11 (+0.13%) Bitcoin USD
65,022.25 -1,789.23 (-2.68%) CMC Crypto 200
1,409.58 -14.52 (-1.02%)
Reneo Pharmaceuticals, Inc. (RPHM)
| Previous close | 1.6750 |
| Open | 1.6600 |
| Bid | 1.6500 x 200 |
| Ask | 1.7200 x 200 |
| Day's range | 1.6600 - 1.7000 |
| 52-week range | 0.9800 - 10.9800 |
| Volume | |
| Avg. volume | 203,419 |
| Market cap | 56.815M |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.5200 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.68 |
GlobeNewswireReneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the fourth quarter and year ended December 31, 2023 and provided a business update. Fourth Quarter and Recent Highlights The pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathi
GlobeNewswireSagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the appointments of two biotechnology industry leaders, Tim Walbert and Paul Hoelscher, to the board of directors of the Company, effective April 1, 2024. “We are fortunate to have Tim and Paul join us at this key st
Insider MonkeyThese Stocks under $10 Are Poised To Explode
In this piece, we will take a look at these stocks under $10 are poised to explode. If you want to skip our introduction to these tricky stocks, jump to These 5 Stocks Under $10 Are Poised To Explode. The US equity markets remain on track for a strong finish in 2023 as major indices […]
